Abstract

Thioguanine 20-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2011 - Volume 15, Number 6

Page(s): 506

Download in electronic PDF format for $75
  • Thioguanine 20-mg/mL Oral Suspension Page 1

Abstract

A formulation for preparing Thioguanine 20-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulations
  • thioguanine
  • antineoplastic agent
  • cancer
  • acute myelogenous leukemia
  • psoriasis
  • childhood acute lymphoblastic leukemia
  • inflammatory bowel syndrome
  • inflammation
  • children
  • skin disorders

Related Categories

  • CANCER AND AIDS
  • DERMATOLOGY
  • FORMULATIONS
  • GASTROENTEROLOGY
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2011
Pg. 506
Thioguanine 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2006
Pg. 68
Thioguanine 40-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jan/Feb 2018
Pg. 51
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 378-384
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Author(s): Narváez Katherine Rivera, Thompson Tara
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
Jan/Feb 2016
Pg. 6-10
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Author(s): Choo Winnie
Sep/Oct 2021
Pg. 420
Sorafenib 20-mg/mL in Oil Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jul/Aug 2011
Pg. 340
Methylprednisolone 4-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 252-262
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
Sep/Oct 2020
Pg. 367-369
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Author(s): Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
Sep/Oct 2023
Pg. 420
Nitazoxanide 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike